Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Assistance Publique Hopitaux De Paris
Sponsor

Assistance Publique Hopitaux De Paris

France Porte 23, 1 Avenue Claude Vellefaux, 75475 Paris, France

About the sponsor

Clinical research includes acute leukemias, multiple myeloma, myelodysplastic syndrome, myelofibrosis, primary CNS lymphoma, and other hematologic malignancies, with strong activity in stem cell transplantation and transplant-related complications.

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Multiple myeloma
  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-host disease

Research also covers lymphoma, plasma cell leukemia, and post-transplant immune complications in adult and pediatric populations.

About Specializations

Assistance Publique Hopitaux De Paris runs clinical trials in conditions such as Haemophagocytic lymphohistiocytosis, Sickle cell disease, Sepsis, Hepatocellular carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

251 clinical trials

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Arthritis infective

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Assistance Publique Hopitaux De Paris

Sickle cell disease

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Imatinib
  • Sponsor:Assistance Publique Hopitaux De Paris

Sepsis

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris

Cutaneous lupus erythematosus

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Assistance Publique Hopitaux De Paris

Renal cell carcinoma

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:RUBIDIUM CHLORIDE
  • Sponsor:Assistance Publique Hopitaux De Paris

Pulmonary tuberculosis

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bedaquiline
  • Sponsor:Assistance Publique Hopitaux De Paris

Pulmonary arterial hypertension

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Assistance Publique Hopitaux De Paris

Cryoglobulinaemia

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Haematological malignancy

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Assistance Publique Hopitaux De Paris

Poisoning

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Charcoal, Activated
  • Sponsor:Assistance Publique Hopitaux De Paris

Inflammatory bowel disease

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:Amphotericin B
  • Sponsor:Assistance Publique Hopitaux De Paris

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.